Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photobiomodulation, Heart Rate Variability, and Acute Stress

NCT: NCT07475858 · NOT_YET_RECRUITING

NCT IDNCT07475858
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2027-08-31
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

Photobiomodulation (PBM) is a form of light therapy that uses red or near-infrared light to influence biological processes. In prior studies, PBM has been shown to improve various physiological functions, including tissue repair, inflammation, and cognitive performance. However, little is known about its impact on autonomic nervous system regulation. Thus, the goal of this study is to evaluate the effects of PBM on vagal activity, as measured by heart rate variability (HRV), in healthy adults undergoing experimental stress.

Frequently Asked Questions

What is Photobiomodulation, Heart Rate Variability, and Acute Stress?

Photobiomodulation, Heart Rate Variability, and Acute Stress is a clinical trial registered under NCT07475858. Current status: NOT_YET_RECRUITING.

What is the status of NCT07475858?

The current status of NCT07475858 (Photobiomodulation, Heart Rate Variability, and Acute Stress) is: NOT_YET_RECRUITING.

When did Photobiomodulation, Heart Rate Variability, and Acute Stress start?

Photobiomodulation, Heart Rate Variability, and Acute Stress started on 2026-07-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.